Patrick Saulnier

Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

Lionel Apétoh, François Ghiringhelli, Antoine Tesnière et al. · Nature Medicine · 2007 · 3K citations

Life Sciences, Immunology, Oncology +16

Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes

David Castel, Cathy Philippe, Raphaël Calmon et al. · Acta Neuropathologica · 2015 · 668 citations · Full text

Medicine, Genetics, Oncology +17

Trastuzumab deruxtecan in metastatic breast cancer with variable HER2 expression: the phase 2 DAISY trial

Fernanda Mosele, Élise Deluche, Amélie Lusque et al. · Nature Medicine · 2023 · 370 citations · Full text

Medicine, Oncology, Pharmacology +17

ERCC1 Isoform Expression and DNA Repair in Non–Small-Cell Lung Cancer

Luc Friboulet, Ken A. Olaussen, Jean‐Pierre Pignon et al. · New England Journal of Medicine · 2013 · 363 citations · Full text

Medicine, Molecular Biology, Oncology +12

The JAK2 617V>F mutation triggers erythropoietin hypersensitivity and terminal erythroid amplification in primary cells from patients with polycythemia vera

Sabrina Dupont, Aline Massé, Chloé James et al. · Blood · 2007 · 188 citations

Medicine, Genetics, Hematology +10